Ixico Regulatory News (IXI)

1 Feb 2008 15:34

Phytopharm PLC01 February 2008 Phytopharm plc Annual Information Update Phytopharm plc (the Company) announces that, in accordance with the requirementsof Prospectus Rule 5.2 issued by the Financial Services Authority, and followingpublication of the Annual Report on 16 January 2008, the following informationhas been published or made available to the public between 13 January 2007 and 1February 2008 inclusive, in compliance with laws and rules dealing with theregulation of securities, issuers of securities and securities markets. For the purpose of this update, only references to the information are provided.Full copies of each item can be found at the locations specified below. Inaccordance with the provisions of Article 27.3 of the Prospectus DirectiveRegulations, we confirm that to the best of our knowledge, information relatingto 'Holdings in Company' and 'Director/PDMR Shareholdings' is up to date at thedate of this announcement, but it is acknowledged that such disclosures may, atany time, become out of date, due to changing circumstances. 1. Announcements made via Regulatory Information Services All documents listed below were published via a regulatory information service on the dates indicated: Date of publication Title 21 January 2008 $1.16m funding for Cogane(TM)16 January 2008 Publication of 2007 annual report and accounts10 January 2008 Director/PDMR shareholding2 January 2008 Total Voting rights14 December 2007 Director/PDMR shareholding4 December 2007 Total Voting Rights29 November 2007 Second price monitoring extension29 November 2007 Price monitoring extension29 November 2007 Final Results27 November 2007 Holding in Company23 November 2007 Appointment of Adviser9 November 2007 Director/PDMR shareholding29 October 2007 Block Listing Cancellation29 October 2007 Additional Listing3 October 2007 New Accounting Reference Date24 September 2007 Joint Development Agreement18 September 2007 Block Listing Interim Review14 September 2007 Director/PDMR shareholding14 September 2007 Director/PDMR shareholding6 August 2007 Director/PDMR shareholding6 August 2007 Director/PDMR shareholding30 July 2007 Research Update26 June 2007 Collaboration & Licence Agreement20 June 2007 Notification of Board change14 June 2007 Result of EGM11 June 2007 Holding(s) in company7 June 2007 Director/PDMR shareholding5 June 2007 Research Update22 May 2007 Notification of EGM17 May 2007 Research Update9 May 2007 Director/PDMR shareholding9 May 2007 Director/PDMR shareholding9 May 2007 Director/PDMR shareholding9 May 2007 Director/PDMR shareholding1 May 2007 Block Listing Interim Review1 May 2007 Interim results24 April 2007 Price Monitoring Extension20 April 2007 Notice of results16 April 2007 Product Launch2 April 2007 Total Voting Rights29 March 2007 Result of AGM26 March 2007 Product Launch19 March 2007 Block Listing Interim Review7 March 2007 Holding(s) in company7 March 2007 Holding(s) in company2 March 2007 Notification of AGM1 March 2007 Second price monitoring extension1 March 2007 Price monitoring extension1 March 2007 Placing of New Ordinary Shares15 January 2007 Price monitoring extension15 January 2007 Annual Information Update 2. Documents published or sent to Shareholders or filed with the UK Listing Authority or submitted to the FSA 16 January 2008 Annual Report 200729 October 2007 Application for admission of securities to the Official List29 October 2007 Form 1 Application for admission of securities to trading22 May 2007 Notice of Extraordinary General Meeting18 May 2007 Interim Report 20072 March 2007 Application for admission of securities to the Official List2 March 2007 Form 1 Application for admission of securities to trading2 March 2007 Notice of Annual General Meeting Certain documents submitted to the FSA can be viewed at the Document ViewingFacility situated at the Financial Services Authority, 25 The North Colonade,Canary Wharf, London E14 5HS The Interim and Annual reports are also available on the Company's websitewww.phytopharm.com 3. Documents filed at Companies House The Company has submitted the following filings to Companies House: 9 January 2008 Form 88(2) - Return of Allotment of Shares17 December 2007 Form 363 Annual Return11 December 2007 Form 88(2) - Return of Allotment of Shares9 November 2007 Form 88(2) - Return of Allotment of Shares3 October 2007 Form 225 - Change of Accounting Date31 July 2007 Form 288(a) Appointment of Director - Mr Alistair Taylor31 July 2007 Form 288(b) Terminating appointment of Director - Dr Paul Whitney14 June 2007 Registration of resolutions passed at EGM and adoption of Articles of Association adopted at EGM28 March 2007 Registration of resolutions passed at AGM7 March 2007 Form 88(2) - Return of Allotment of Shares Copies of these documents can be obtained from Companies House, Crown Way,Cardiff CF14 3UZ (Telephone 0870 3333 636, email at enquiries@companies-house.gov.uk) or, if you are a registered user, through CompaniesHouse Direct at www.companies-house.gov.uk Copies of all documents referred to above are also available for inspection atthe Company's registered office (Corpus Christi House, 9 West Street,Godmanchester, Cambs PE29 2HY, United Kingdom) during normal business hours orby request from the Company Secretary. For further information, please contact: Zoe McGowan, Company Secretary Phytopharm plc Tel No: +44 (0)1480 437697 Further information about Phytopharm can be found on the Company's websitewww.phytopharm.com This information is provided by RNS The company news service from the London Stock Exchange